Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21797863 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents
Condition: Migraine Disorders
Intervention: Drug: Combination Tablet of Treximet (sumatriptan/naproxen sodium)

Indicates status has not been verified in more than two years